Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 415

1.

Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.

Pham PV, Phan NL, Nguyen NT, Truong NH, Duong TT, Le DV, Truong KD, Phan NK.

J Transl Med. 2011 Dec 7;9:209. doi: 10.1186/1479-5876-9-209.

PMID:
22152097
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.

Duru N, Fan M, Candas D, Menaa C, Liu HC, Nantajit D, Wen Y, Xiao K, Eldridge A, Chromy BA, Li S, Spitz DR, Lam KS, Wicha MS, Li JJ.

Clin Cancer Res. 2012 Dec 15;18(24):6634-47. doi: 10.1158/1078-0432.CCR-12-1436. Epub 2012 Oct 22.

PMID:
23091114
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.

Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, Gottesman MM, Varticovski L, Ambudkar SV.

J Natl Cancer Inst. 2010 Nov 3;102(21):1637-52. doi: 10.1093/jnci/djq361. Epub 2010 Oct 8.

PMID:
20935265
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.

Wei L, Liu TT, Wang HH, Hong HM, Yu AL, Feng HP, Chang WW.

Breast Cancer Res. 2011 Oct 24;13(5):R101. doi: 10.1186/bcr3042.

PMID:
22023707
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Autophagy positively regulates the CD44(+) CD24(-/low) breast cancer stem-like phenotype.

Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, Martin-Castillo B, Vellon L, Menendez JA.

Cell Cycle. 2011 Nov 15;10(22):3871-85. doi: 10.4161/cc.10.22.17976. Epub 2011 Nov 15.

PMID:
22127234
[PubMed - indexed for MEDLINE]
Free Article
6.

CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.

Idowu MO, Kmieciak M, Dumur C, Burton RS, Grimes MM, Powers CN, Manjili MH.

Hum Pathol. 2012 Mar;43(3):364-73. doi: 10.1016/j.humpath.2011.05.005. Epub 2011 Aug 10.

PMID:
21835433
[PubMed - indexed for MEDLINE]
7.

Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.

Leth-Larsen R, Terp MG, Christensen AG, Elias D, Kühlwein T, Jensen ON, Petersen OW, Ditzel HJ.

Mol Med. 2012 Sep 25;18:1109-21. doi: 10.2119/molmed.2012.00091.

PMID:
22692575
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells.

Gupta V, Bhinge KN, Hosain SB, Xiong K, Gu X, Shi R, Ho MY, Khoo KH, Li SC, Li YT, Ambudkar SV, Jazwinski SM, Liu YY.

J Biol Chem. 2012 Oct 26;287(44):37195-205. doi: 10.1074/jbc.M112.396390. Epub 2012 Aug 30.

PMID:
22936806
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Breast cancer stem cells and intrinsic subtypes: controversies rage on.

Nakshatri H, Srour EF, Badve S.

Curr Stem Cell Res Ther. 2009 Jan;4(1):50-60. Review.

PMID:
19149630
[PubMed - indexed for MEDLINE]
10.

Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.

Kagara N, Huynh KT, Kuo C, Okano H, Sim MS, Elashoff D, Chong K, Giuliano AE, Hoon DS.

Am J Pathol. 2012 Jul;181(1):257-67. doi: 10.1016/j.ajpath.2012.03.019. Epub 2012 May 21.

PMID:
22626806
[PubMed - indexed for MEDLINE]
Free Article
11.

Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction.

Huang M, Li Y, Zhang H, Nan F.

J Exp Clin Cancer Res. 2010 Jun 22;29:80. doi: 10.1186/1756-9966-29-80.

PMID:
20569497
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts.

Cufi S, Corominas-Faja B, Vazquez-Martin A, Oliveras-Ferraros C, Dorca J, Bosch-Barrera J, Martin-Castillo B, Menendez JA.

Oncotarget. 2012 Apr;3(4):395-8.

PMID:
22565037
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway.

McClements L, Yakkundi A, Papaspyropoulos A, Harrison H, Ablett MP, Jithesh PV, McKeen HD, Bennett R, Donley C, Kissenpfennig A, McIntosh S, McCarthy HO, O'Neill E, Clarke RB, Robson T.

Clin Cancer Res. 2013 Jul 15;19(14):3881-93. doi: 10.1158/1078-0432.CCR-13-0595. Epub 2013 Jun 5.

PMID:
23741069
[PubMed - indexed for MEDLINE]
Free Article
14.

Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.

Vesuna F, Lisok A, Kimble B, Raman V.

Neoplasia. 2009 Dec;11(12):1318-28.

PMID:
20019840
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

[Expression of breast cancer resistance protein and p-glycoprotein in residual breast cancer tissue after chemotherapy and its correlation with cancer stem cells].

Qu HB, Fan YM, Han ML, Luo HJ, Xie J, Liu H, Liu H, Wu CY, Tang WX.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Apr;35(2):171-6. doi: 10.3881/j.issn.1000-503X.2013.02.009. Chinese.

PMID:
23643006
[PubMed - indexed for MEDLINE]
Free Article
16.

Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.

Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, Tamaki Y, Noguchi S.

Clin Cancer Res. 2009 Jun 15;15(12):4234-41. doi: 10.1158/1078-0432.CCR-08-1479. Epub 2009 Jun 9.

PMID:
19509181
[PubMed - indexed for MEDLINE]
Free Article
17.

Tumor associated macrophage × cancer cell hybrids may acquire cancer stem cell properties in breast cancer.

Ding J, Jin W, Chen C, Shao Z, Wu J.

PLoS One. 2012;7(7):e41942. doi: 10.1371/journal.pone.0041942. Epub 2012 Jul 25.

PMID:
22848668
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

CD44+/CD24- breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties.

Sun H, Jia J, Wang X, Ma B, Di L, Song G, Ren J.

Clin Transl Oncol. 2013 Jan;15(1):46-54. doi: 10.1007/s12094-012-0891-2. Epub 2012 Jul 20.

PMID:
22855175
[PubMed - indexed for MEDLINE]
19.

Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.

Ricardo S, Vieira AF, Gerhard R, Leitão D, Pinto R, Cameselle-Teijeiro JF, Milanezi F, Schmitt F, Paredes J.

J Clin Pathol. 2011 Nov;64(11):937-46. doi: 10.1136/jcp.2011.090456. Epub 2011 Jun 16.

PMID:
21680574
[PubMed - indexed for MEDLINE]
20.

Cell specific CD44 expression in breast cancer requires the interaction of AP-1 and NFκB with a novel cis-element.

Smith SM, Cai L.

PLoS One. 2012;7(11):e50867. doi: 10.1371/journal.pone.0050867. Epub 2012 Nov 30.

PMID:
23226410
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk